These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 502411)

  • 1. [Plasma antithrombin-III in nephrotic syndrome patients].
    Poliantseva LR; Andreenko GV; Podorol'skaia LV
    Klin Med (Mosk); 1979 Aug; 57(8):38-43. PubMed ID: 502411
    [No Abstract]   [Full Text] [Related]  

  • 2. [Howie's antithrombin activity and thrombin inhibitors in the nephrotic syndrome].
    Campo G; Modena N; Gallo A; Ciaffoni S
    Quad Sclavo Diagn; 1985 Mar; 21(1):106-16. PubMed ID: 2414802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renal pathology in the Ivory Coast: exploration and functional activity of antithrombin iii].
    Blavy G; Kouame C
    Nephrologie; 1994; 15(6):387-9. PubMed ID: 7862227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in blood coagulation and fibrinolysis in the nephrotic syndrome.
    Thomson C; Forbes CD; Prentice CR; Kennedy AC
    Q J Med; 1974 Jul; 43(171):399-407. PubMed ID: 4547474
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma heparin cofactor II and antithrombin III concentrations in adult nephrotic syndrome.
    Hannedouche T; Fischer AM; Blanche P; Tapon-Brétaudière J; Ganeval D
    Clin Nephrol; 1987 Dec; 28(6):305-6. PubMed ID: 3442960
    [No Abstract]   [Full Text] [Related]  

  • 6. Coagulation studies in 45 cases of nephrotic syndrome without uremia.
    Kanfer A; Kleinknecht D; Broyer M; Josso F
    Thromb Diath Haemorrh; 1970 Dec; 24(3):562-71. PubMed ID: 4994004
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative study of coagulation in the primary nephrotic syndrome and nephrotic syndrome secondary to renal amyloidosis].
    Ben Maïz H; Ayed K; Kheder A; Kastalli R; Kouki F; EL Matri A; Ben Ayed H
    J Urol Nephrol (Paris); 1979 Dec; 85(12):840-5. PubMed ID: 554868
    [No Abstract]   [Full Text] [Related]  

  • 8. [State of the blood coagulation and fibrinolysis systems in nephrotic syndrome].
    Tareev EM; Andreenko GV; Poliantseva LR; Torik ZhN; Smirnova TA
    Klin Med (Mosk); 1976 Aug; 54(8):25-33. PubMed ID: 1011770
    [No Abstract]   [Full Text] [Related]  

  • 9. [Replacement therapy of acquired antithrombin III deficiency in experimental nephrotic syndrome].
    Bashkov GV; Kalishevskaia TM
    Biull Eksp Biol Med; 1987 Sep; 104(9):278-81. PubMed ID: 3663906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Coagulation and fibrinolysis proteins in nephrotic syndromes in children].
    Loirat C; Pillion G; Schlegel N; Douenias R; Mathieu H
    Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LVI-LXIII. PubMed ID: 539878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood coagulation, fibrinolysis and the mercurial nephrotic syndrome.
    Barr RD; Ouna N; Rees PH
    J Trop Med Hyg; 1976 Oct; 79(10):235-6. PubMed ID: 1011317
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fibrinolytic properties of the blood plasma, urine and edematous fluids of nephrotic syndrome patients].
    Andreenko GV; Poliantseva LR; Podorol'skaia LV
    Ter Arkh; 1982; 54(7):53-7. PubMed ID: 7135224
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical significance of indices of blood coagulation and anticoagulation systems of the blood in hemorrhagic fever with nephrotic syndrome].
    Kashapova RV
    Ter Arkh; 1968 Mar; 40(3):82-5. PubMed ID: 5669290
    [No Abstract]   [Full Text] [Related]  

  • 14. Antithrombin functional activity after a fatty meal in normal subjects, familial hyperlipidemia, and nephrotic syndrome.
    Gomperts ED; Zucker M; Feesey M; Russel D; Salant D; Joffe BI; Mendelsohn D; Seftel H
    J Lab Clin Med; 1977 Sep; 90(3):529-35. PubMed ID: 578151
    [No Abstract]   [Full Text] [Related]  

  • 15. High plasma levels of protein C activity and antigen in the nephrotic syndrome.
    Mannucci PM; Valsecchi C; Bottasso B; D'Angelo A; Casati S; Ponticelli C
    Thromb Haemost; 1986 Feb; 55(1):31-3. PubMed ID: 3754658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of patients with atherosclerosis and renal disease with respect to lipoprotein types, fibrinolysis, and carbohydrate tolerance.
    Wardle EN; Menon IS; Anderson J
    Q J Med; 1972 Jan; 41(161):15-23. PubMed ID: 5070986
    [No Abstract]   [Full Text] [Related]  

  • 17. [Blood coagulation and fibrinolysis in patients with renal diseases (author's transl)].
    Yamabe H
    Nihon Jinzo Gakkai Shi; 1979 May; 21(3):219-31. PubMed ID: 470232
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in several blood coagulation parameters in the nephrotic syndrome].
    Gasparotto ML; Bertoli M; Bertaglia E; Vertolli U; Varchetta V; Favaro P; Rebeschini M; Di Lavoro D; Romagnoli GF
    Minerva Nefrol; 1981; 28(1):15-9. PubMed ID: 6793942
    [No Abstract]   [Full Text] [Related]  

  • 19. [Plasma and urinary antithrombin III in the nephrotic syndrome in adults].
    Antelin CH; Gouault-Heilmann M; Levent M; Bernard D; Ruszniewski P; Lagrue G
    Ann Med Interne (Paris); 1983; 134(8):713-6. PubMed ID: 6666909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of selected parameters of hemostasis in patients with nephrotic syndrome].
    Rowiński M; Rydzewski A; Małyszko JS; Małyszko J; Myśliwiec M
    Przegl Lek; 1994; 51(2):77-81. PubMed ID: 8058973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.